These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36221349)
1. Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: A retrospective analysis. Du X; Dong J; Yan K; Wang X; Shen W; Zhu S Medicine (Baltimore); 2022 Oct; 101(40):e30305. PubMed ID: 36221349 [TBL] [Abstract][Full Text] [Related]
2. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. Fu X; Li T; Dai Y; Li J BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297 [TBL] [Abstract][Full Text] [Related]
3. The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study. Huang C; Wang M; Chen L; Wang H; Huang D; Shi J; Zhang W; Tian Y; Zhu Y BMC Cancer; 2023 Jun; 23(1):505. PubMed ID: 37270496 [TBL] [Abstract][Full Text] [Related]
4. Predictive potential of preoperative Naples prognostic score-based nomogram model for the prognosis in surgical resected thoracic esophageal squamous cell carcinoma patients: A retrospective cohort study. Guo XW; Ji L; Xi XX; Zhao WW; Liu YC; Zhou SB; Ji SJ Medicine (Baltimore); 2024 May; 103(18):e38038. PubMed ID: 38701277 [TBL] [Abstract][Full Text] [Related]
5. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy. Xu Z; Ke H; Zheng B; Lin C; Zhang Y; Wang L; Lin Y; Ye Y; Cai L; You M; Chen J; Xu Y Cancer Control; 2023; 30():10732748231185025. PubMed ID: 37339928 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796 [No Abstract] [Full Text] [Related]
7. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
8. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma. Chen L; Zeng H; Du Z; Zhao Y; Ma X Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392 [TBL] [Abstract][Full Text] [Related]
9. Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma. Yang Y; Tan H; Lu Y; Mei J; Zhang M; Bai M; Wang X; Ge S; Ning T; Zhang L; Ji Z; Duan J; Sun Y; Wang F; Liu R; Li H; Deng T BMC Cancer; 2024 Feb; 24(1):249. PubMed ID: 38389042 [TBL] [Abstract][Full Text] [Related]
10. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy. Huang Z; Zheng Q; Yu Y; Zheng H; Wu Y; Wang Z; Liu L; Zhang M; Liu T; Li H; Li J Sci Rep; 2022 Mar; 12(1):3535. PubMed ID: 35241740 [TBL] [Abstract][Full Text] [Related]
12. A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma. Liang S; Li C; Gao Z; Li J; Zhao H; Yu J; Meng X Int Immunopharmacol; 2021 Jan; 90():107178. PubMed ID: 33218939 [TBL] [Abstract][Full Text] [Related]
13. A nomogram based on hematological markers to predict radiosensitivity in patients with esophageal squamous cell carcinoma. Sun L; Wei P; Ge S; Zheng J; Ye S; Zhang Y Medicine (Baltimore); 2023 Mar; 102(11):e33282. PubMed ID: 36930089 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment. Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K Front Oncol; 2023; 13():1144875. PubMed ID: 37035159 [TBL] [Abstract][Full Text] [Related]
15. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma]. Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452 [No Abstract] [Full Text] [Related]
16. The Predictive Value of Systemic Inflammatory Factors in Advanced, Metastatic Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab. Liu J; Gao D; Li J; Hu G; Liu J; Liu D Onco Targets Ther; 2022; 15():1161-1170. PubMed ID: 36238132 [TBL] [Abstract][Full Text] [Related]
17. The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy. Man Q; Li P; Fan J; Yang S; Xing C; Bai Y; Hu M; Wang B; Zhang K BMC Cancer; 2024 Apr; 24(1):464. PubMed ID: 38616289 [TBL] [Abstract][Full Text] [Related]
18. Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy. Yang J; Zheng J; Qiu J; Zhang M; Liu L; Wang Z; Zheng Q; Liu Y; Chen M; Li J J Immunol Res; 2023; 2023():4275998. PubMed ID: 37228442 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer. Chen L; Li Q; Wang Y; Yang J; Ma X Int Immunopharmacol; 2019 Dec; 77():106001. PubMed ID: 31734191 [TBL] [Abstract][Full Text] [Related]
20. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy. Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]